Verde Science, Inc. Announces the Appointment of Mr. Bradley J. Dixon, J.D. to the Board of Directors
18 Junho 2014 - 3:36PM
Marketwired
Verde Science, Inc. Announces the Appointment of Mr. Bradley J.
Dixon, J.D. to the Board of Directors
Experienced Legal Expert Appointed to Help Guide Company Through
the Legal Challenges of the Growing Medical Marijuana Industry
LOS ANGELES, CA--(Marketwired - Jun 18, 2014) - Verde Science,
Inc. (OTCQB: VRCI) is pleased to announce the appointment of
Bradley J. Dixon, J.D. to the Board of Directors. Mr. Dixon is a
trial attorney and partner in the Boise, Idaho office of Stoel
Rives, LLP, which has locations throughout the northwest and
California. Mr. Dixon is ranked by Chambers and Partners and was
named in the 2013 Mountain States Directory of Super Lawyers. He
has a wide range of litigation experience, which includes
Agricultural, Natural Resources, Labor and Employment, and Product
Liability cases. Mr. Dixon's trial experience representing clients
through complex litigation on a broad range of disputes including
complex commercial litigation, employment, insurance coverage,
products liability, title insurance, foreclosure and bankruptcy
trial practice, as well his governmental affairs service experience
meshes well with the future needs of Verde Science.
As Verde Science has developed into its current complex
structure, it became apparent that legal oversight from an
experienced attorney such as Mr. Dixon was a requirement. The
business now consists of multiple interconnected facets, which
include the scientific and engineering sides of the aeroponics and
hydroponics marijuana grow business, management consulting
services, capital funding services, and basic research and
development into future prescription drugs.
Ken Berscht, CEO of Verde Science, stated, "I am very pleased to
have Brad on our Board of Directors as he brings a tremendous
amount of relevant experience to our company. With his broad legal
background he can help guide us through the challenges of this
business as it matures and spreads to more and more jurisdictions.
Brad broadens the knowledge base of our board which will help
position Verde Science as dominant force in the medical marijuana
market."
About Verde Science Verde Science plans to take an
all-encompassing, integrated public health approach to medical
marijuana with a focus on becoming the leader in providing services
to legal, licensed cannabis cultivators and dispensaries and their
patient community. Verde's focus, in collaboration with its
partners, is on deploying an advanced array of technical services
to foster an integrated health care model in legal jurisdictions in
North America.
The Company provides a variety of products and services to its
clients by using best practices to ensure the best quality of
product, produced with focus on cost control and legal compliance.
Verde Science is meticulous, measured and diligent with an absolute
focus on compliance while offering growers and their patient
community unsurpassed, fully integrated, holistic health care
products and programs.
Verde Science is one of the initial corporate players in the
medical marijuana industry providing sophistication, controls,
standards and innovation. The company has and will continue to
assemble a highly experienced team that will deploy
state-of-the-art technology and a superior methodology to enter and
take meaningful market share that can be repeated and expanded as
more and more jurisdictions adopt legal use of cannabis products to
address health care issues.
Safe Harbor Statements Certain information contained in this
news release constitutes "forward-looking statements" as such term
is used in applicable United States and Canadian laws. Generally,
these forward-looking statements can be identified by the use of
forward-looking terminology such as "expects" or "does not expect",
"is expected", "anticipates" or "does not anticipate", "plans",
"estimates", "intends" or "believes", or that certain actions,
events or results "may", "could", "would", "might" or "will be
taken", "occur", or "be achieved". Forward-looking statements
are based on the opinions and estimates of management as of the
date such statements are made, and are subject to known and unknown
risks, uncertainties and other factors that may cause the actual
results, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements. Many of these factors are beyond the
Company's ability to control or predict. Important factors that may
cause actual results to differ materially and that could impact the
Company and the statements contained in this news release can be
found in the Company's filings with the SEC. Such risks and other
factors include, among others, the ability to locate and acquire
suitable interests in alternative medicine manufacturing operations
on terms acceptable to the Company, the availability of financing
on acceptable terms, accidents, labor disputes, acts of God and
other risks of the alternative medicine industry including, without
limitation, delays in obtaining governmental approvals or permits,
title disputes or claims limitations on insurance coverage. The
Company believes that the expectations reflected in the
forward-looking statements included in this news release are
reasonable; however, no assurance can be given that these
expectations will prove to be correct, and such forward-looking
statements should not be unduly relied upon. The Company assumes no
obligation to update or supplement any forward-looking statements
whether as a result of new information, future events or
otherwise.
For further information please contact: Harp Sangha
Chairman/Director 1-858-210-0236
harpsangha@shaw.ca Torrey Hills Capital Jim MacDonald/Clay Chase
1-858-759-9902
Verde Science (CE) (USOTC:VRCI)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Verde Science (CE) (USOTC:VRCI)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
